The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Tert-butyl (3-carbamoyl-1-(2-((2-((3-chloro-2-fluorobenzyl)amino)-2-oxoethyl)(cyclopropyl)amino)-2-oxoethyl)-1H-indazol-5-yl)carbamate ID: ALA5220843
PubChem CID: 168298056
Max Phase: Preclinical
Molecular Formula: C27H30ClFN6O5
Molecular Weight: 573.02
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)OC(=O)Nc1ccc2c(c1)c(C(N)=O)nn2CC(=O)N(CC(=O)NCc1cccc(Cl)c1F)C1CC1
Standard InChI: InChI=1S/C27H30ClFN6O5/c1-27(2,3)40-26(39)32-16-7-10-20-18(11-16)24(25(30)38)33-35(20)14-22(37)34(17-8-9-17)13-21(36)31-12-15-5-4-6-19(28)23(15)29/h4-7,10-11,17H,8-9,12-14H2,1-3H3,(H2,30,38)(H,31,36)(H,32,39)
Standard InChI Key: VBJJJLBIQQMABQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
40 43 0 0 0 0 0 0 0 0999 V2000
5.4426 1.4760 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.4487 0.6510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7371 0.2335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0195 0.6407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3082 0.2229 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5907 0.6302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5846 1.4551 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8792 0.2124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1617 0.6196 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.1617 1.4447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5750 2.1604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7501 2.1596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4504 0.2019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2671 0.6091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9785 0.1913 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7236 0.5740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9430 1.3693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7386 1.5771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3177 0.9897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0974 0.1912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2985 -0.0115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9141 -0.7315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0998 -0.6005 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3213 -1.4490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1463 -1.4551 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.9036 -2.1604 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.4564 -0.6230 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7432 -0.5950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4627 -0.9978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1698 -0.5808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1637 0.2444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8751 0.6622 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-4.1146 1.2032 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.6978 0.6198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4948 0.8334 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.4844 -0.1770 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.0782 0.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.8751 0.4636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.8647 -0.5467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.6616 -0.3333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 2 0
4 3 1 0
5 4 1 0
6 5 1 0
6 7 2 0
8 6 1 0
9 8 1 0
10 9 1 0
10 11 1 0
11 12 1 0
10 12 1 0
13 9 1 0
14 13 1 0
15 14 1 0
16 15 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
21 22 1 0
15 23 1 0
22 23 2 0
22 24 1 0
24 25 1 0
24 26 2 0
13 27 2 0
3 28 1 0
28 29 2 0
29 30 1 0
31 2 1 0
30 31 2 0
31 32 1 0
19 33 1 0
33 34 1 0
34 35 1 0
34 36 2 0
35 37 1 0
37 38 1 0
37 39 1 0
37 40 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 573.02Molecular Weight (Monoisotopic): 572.1950AlogP: 3.58#Rotatable Bonds: 9Polar Surface Area: 148.65Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.78CX Basic pKa: ┄CX LogP: 2.52CX LogD: 2.52Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.36Np Likeness Score: -2.06
References 1. Zhang W, Wu M, Vadlakonda S, Juarez L, Cheng X, Muppa S, Chintareddy V, Vogeti L, Kellogg-Yelder D, Williams J, Polach K, Chen X, Raman K, Babu YS, Kotian P.. (2022) Scaffold hopping via ring opening enables identification of acyclic compounds as new complement Factor D inhibitors., 74 [PMID:36272185 ] [10.1016/j.bmc.2022.117034 ]